YHYurii Husiev

Yurii Husiev

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yurii Husiev has a total of 76 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ДОСЛІДЖЕННЯ НАПРУЖЕНО-ДЕФОРМОВАНОГО СТАНУ ЕЛЕМЕНТІВ КОНСТРУКЦІЙ ТРДД В УМОВАХ ПІДВИЩЕНИХ ТЕМПЕРАТУР

    by Serhiy Kryhin, Dmytrо Kozel, Yuriy Husyev, Yuriy Torba

    This article investigates the development and methodology of a high-temperature strain gauge (HTS) designed to monitor the stress-strain state (SSS) of structures operating under extreme thermal conditions (650–700 °C). The primary objective is to scientifically substantiate and practically test an HTS capable of measuring deformation parameters with high accuracy during intense heating. To achieve this, the study introduces an innovative design for the sensitive elements (SE): a rectangular socket configuration featuring vertical integration ("one above the other") within a specialized high-temperature cement binder. This engineering solution enables the simultaneous, accurate recording of longitudinal and transverse deformations, effectively identifying the force vector on the test object. The research combines numerical modeling using finite element analysis (FEA) in ANSYS with full-scale physical experiments, demonstrating a high degree of data convergence. The operability and efficiency of the developed device were validated by analyzing the SSS of a bracket that secures the flame tube fairing in a gas turbine engine combustion chamber. During bench tests across all standard operating modes, these strain gauges provided a comprehensive assessment of the unit's strength and reliability. Ultimately, the proposed HTS design and methodology offer an effective and reliable tool for monitoring critical aircraft engine components. Practical implementation of this technology supports real-world measures to optimize and extend the service life of engineering structures, confirming its value in modern testing practices.

  • Open Access

    Тензометричний пристрій і метод його використання при дослідженні напружено-деформованого стану та температурних деформацій високо-нагрітих елементів газотурбінних двигунів

    by Serhiy Kryhin, Yuriy Husyev, Yuriy Torba

    The subject of the study was the development and testing of a high-temperature strain gauge for measuring static and temperature deformations in the blades, disks, and housing elements of gas turbine engines and other power machines operated at temperatures up to 700 °C. A comparison was made with commercial samples of low- and high-temperature strain gauges, and recommendations were presented for research on gas turbine engines at elevated temperatures. The purpose of the study of the article was to develop a strain gauge considering the peculiarities of the operation of elements of gas turbine engines and other power machines, in particular, high temperatures, aggressive environments, and mechanical loads. The task was to propose a design for a strain gauge device that can be used to measure temperature, static, and temperature deformations, and a method for the temperature compensation of imaginary deformations. The deformations were measured by the strain gauge method using a strain gauge device that was mounted on the surface of the disk, which was subjected to temperature stresses. To verify the obtained experimental results, the authors conducted two analytical solutions of the disk strength. The geometric parameters and properties of the disk material, as well as the temperature gradients in it, correspond to the experimental ones. In the first variant of the analytical solution of the thermally stressed state of the disk, a mathematical model of disk loading was used, in the second variant, the solution was performed using FEM in the ANSYS system. The obtained results of the article showed sufficient accuracy and reliability for the strain gauge device when operating at high temperatures. With a temperature gradient of less than 50 °C along the length of the SE, the error does not exceed 400 μm/m. The conclusion shows that the proposed sensor performs sufficient temperature compensation at temperatures up to 700 °C and provides signal stability over time. The practical significance of the work lies in increasing the reliability of diagnostics and forecasting the service life stability of gas turbine plant elements.

  • Open Access

    A Sterically Open Ruthenium-Based Photocage Activated by Red and Far-Red Light for a Wide Range of Drugs

    by Yurii Husiev, Sina Katharina Götzfried, Matthijs L. A. Hakkennes, Daria Kotova, Isabelle Tutein Nolthenius, Corjan van de Griend, Andrew C. Johns, Selda Abyar, Maxime A. Siegler, Alexander Kornienko, et al.

    Herein we report a novel ruthenium-based photocage for photoactivated chemotherapy (PACT) that can deliver a variety of experimental and clinically approved anticancer drugs using red and far-red light. The new caging moiety is based on the polypyridine pentadentate ligand N6,N6″-di(pyridin-2-yl)-[2,2':6',2″-terpyridine]-6,6″-diamine (baptpy), which once coordinated to ruthenium(II) can form the helically chiral [Ru(baptpy)(L)]X2 prodrugs [6]Cl2-[16]Cl2. A total of ten active pharmaceutical ingredients (L) have been successfully conjugated to this photocage, including well-known agents such as Albendazole, Gemcitabine, Bosutinib, Neratinib, and Ponatinib. The X-ray crystal structures of seven complexes were obtained, showing coordination of ligand L via its thioether, nitrile, pyridine or imidazole moieties. All prepared ruthenium compounds showed selective photosubstitution of the monodentate ligand under 625 (red) and 730 nm (far-red) light irradiation with good (0.005-0.05) to excellent (0.05-0.10) quantum yields, while no singlet oxygen generation was observed. As calculated by density functional theory and time-dependent density functional theory, the high-wavelength light absorption of [Ru(baptpy)(L)]X2 complexes and their favorable ligand exchange behavior under low-energy light are the consequence of the strong distortion of the first coordination sphere, combined with the electronic effect of the amine bridges of the baptpy ligand. Preliminary biological activity of complexes [6]Cl2-[16]Cl2 was investigated in vitro by cytotoxicity studies in the dark and under red light irradiation in normoxic A375 and U-87MG human cancer cell lines. Several of the obtained PACT prodrugs exhibited micro- to nanomolar EC50 values upon red light activation, with photoindexes as high as 7.5. [7]Cl2 showed a photoindex of 6.2 upon far-red light activation (730 nm), which is unprecedented for a ruthenium-based PACT, while the ruthenium cage itself showed very low toxicity in both the dark and light irradiation.


  • Open Access

    Structure over States: Planarity, Not Energy, Dictates Photoactivation in Ru(II) PACT Agents

    by Matthijs L. A. Hakkennes, Irene Regeni, Yurii Husiev, Valeriia D. Andreeva, Maxime A. Siegler, Francesco Buda, Sylvestre Bonnet

    Photoactivated chemotherapy (PACT) employs light to precisely control the activity of prodrugs, enabling spatial and temporal regulation of therapeutic effects while minimizing systemic toxicity. Transition-metal complexes, particularly Ru(II) polypyridyl compounds, have emerged as promising PACT agents due to their ability to undergo photodissociation via triplet excited states. However, rationalizing and predicting photosubstitution quantum yields remain challenging due to complex excited-state dynamics, solvent effects, and limitations of traditional modeling approaches. In this study, we synthesized nine Ru(II) complexes incorporating a monodentate thioether ligand, a terpyridine ligand, and various bidentate polypyridyl ligands. Upon red-light irradiation in aqueous solution, these complexes showed selective photosubstitution of the thioether by an aqua ligand. Despite similar absorption properties, these compounds exhibited markedly different photosubstitution quantum yields that static DFT calculations failed to explain. These modeling difficulties prompted us to develop a novel triplet-state molecular dynamics protocol using the GFN-xTB method, explicit solvation, and enhanced sampling techniques. Our approach enabled full simulations of the ligand exchange process on the triplet hypersurface and comparison to experimental data. It revealed that both cis and trans substitution of the thioether by a water molecule is possible; it was also able to distinguish between photoactive and photoinactive compounds. Unexpectedly, we found that the deviation from planarity of the bidentate ligand, rather than the energy levels of the different triplet excited states (3MLCT, 3MC) involved in the photosubstitution reaction, was the primary determinant of photosubstitution efficiency, as it promoted access to the trans photosubstitution pathway. Furthermore, our simulations uniquely identified whether dissociative, interchange, or associative mechanisms governed the reactivity of each complex. These results provide for the first time mechanistic insights into Ru(II)-based photosubstitution reactions in a solvent and offer a practical, scalable computational tool for designing next-generation PACT agents with optimized light-responsive properties.


  • Open Access

    Похибки передачі відносних деформацій у тензометричному пристрої при підвищеній температурі

    by Serhiy Kryhin, Yuriy Husyev, Yuriy Torba, Oleksandr Bilohub

    The subject of study in this article is the distribution of relative deformations in the system of the strain gauge used in the study. This study aims to identify factors and study their influence on the accuracy of measuring relative deformations. Task: to conduct a simulation of the distribution of deformations to assess the distortions caused by the ineffective transfer of stresses through the bonding layer, and to study the influence of design factors on the measurement error. Obtaining reliable data and making adjustments from a strain gauge of increased thickness operating in high-temperature conditions. Method for solving the problem: computational and analytical. Thus, the results of the computational experiment demonstrate the high efficiency of the developed strain gauge device, particularly under significant temperature gradients. The key factor ensuring this efficiency is not only a stable strain transfer coefficient, which minimizes the influence of external factors on the accuracy of measurements, but also effective leveling of the thermally caused additive error. This process is achieved by the mutual arrangement of strain gauges and the use of a high-temperature insulator-connector material. The obtained data emphasize the potential of using the device in environments with unstable thermal conditions, where accurate deformation measurements are critical for ensuring reliable operation and monitoring the condition of the parts under study. Conclusions. The deformation characteristics of the strain gauge device installed on the part model were investigated using computational experiment methods when heat flow was applied and loaded. The sensitive elements perceive the deformation from the part at the level of 96%. The research results have theoretical and practical significance for increasing the accuracy of research at elevated temperatures and the possibility of making corrections to the measurement results if necessary. Further research and improvement of the strain gauge device are proposed, and the advantages of the used technical solution are analyzed.

  • Open Access

    Cyclic Ruthenium-Peptide Prodrugs Penetrate the Blood–Brain Barrier and Attack Glioblastoma upon Light Activation in Orthotopic Zebrafish Tumor Models

    by Liyan Zhang, Gangyin Zhao, Trevor Dalrymple, Yurii Husiev, Hildert Bronkhorst, Gabriel Forn-Cuní, Bruno Lopes-Bastos, Ewa Snaar-Jagalska, Sylvestre Bonnet

    The blood-brain barrier (BBB) presents one of the main obstacles to delivering anticancer drugs in glioblastoma. Herein, we investigated the potential of a series of cyclic ruthenium-peptide conjugates as photoactivated therapy candidates for the treatment of this aggressive tumor. The three compounds studied, Ru-p(HH), Ru-p(MH), and Ru-p(MM) ([Ru(Ph2phen)2 (Ac-X1RGDX2-NH2)]Cl2 with Ph2phen = 4,7-diphenyl-1,10-phenanthroline and X1, X2 = His or Met), include an integrin-targeted pentapeptide coordinated to a ruthenium warhead via two photoactivated ruthenium-X1,2 bonds. Their photochemistry, activation mechanism, tumor targeting, and antitumor activity were meticulously addressed. A combined in vitro and in vivo study revealed that the photoactivated cell-killing mechanism and their O2 dependence were strongly influenced by the nature of X1 and X2. Ru-p(MM) was shown to be a photoactivated chemotherapy (PACT) drug, while Ru-p(HH) behaved as a photodynamic therapy (PDT) drug. All conjugates, however, showed comparable antitumor targeting and efficacy toward human glioblastoma 3D spheroids and orthotopic glioblastoma tumor models in zebrafish embryos. Most importantly, in this model, all three compounds could effectively cross the BBB, resulting in excellent targeting of the tumors in the brain.


  • Open Access

    Oxygen-Dependent Interactions between the Ruthenium Cage and the Photoreleased Inhibitor in NAMPT-Targeted Photoactivated Chemotherapy

    by Selda Abyar, Luojiao Huang, Yurii Husiev, Ludovic Bretin, Bobby Chau, Vadde Ramu, Jacob Hendricus Wildeman, Kimberley Belfor, Lukas S. Wijaya, Vera E. van der Noord, et al.

    Photoactivated chemotherapy agents form a new branch of physically targeted anticancer agents with potentially lower systemic side effects for patients. On the other hand, limited information exists on the intracellular interactions between the photoreleased metal cage and the photoreleased anticancer inhibitor. In this work, we report a new biological study of the known photoactivated compound Ru-STF31 in the glioblastoma cancer cell line, U87MG. Ru-STF31 targets nicotinamide phosphoribosyltransferase (NAMPT), an enzyme overexpressed in U87MG. Ru-STF31 is activated by red light irradiation and releases two photoproducts: the ruthenium cage and the cytotoxic inhibitor STF31. This study shows that Ru-STF31 can significantly decrease intracellular NAD+ levels in both normoxic (21% O2) and hypoxic (1% O2) U87MG cells. Strikingly, NAD+ depletion by light activation of Ru-STF31 in hypoxic U87MG cells could not be rescued by the addition of extracellular NAD+. Our data suggest an oxygen-dependent active role of the ruthenium photocage released by light activation.


  • Open Access

    Oxygen-dependent interactions between the ruthenium cage and the photoreleased inhibitor in NAMPT-targeted photoactivated chemotherapy

    by Selda Abyar, Lujiao Huang, Yurii Husiev, Ludovic Bretin, Bobby Chau, Vadde Ramu, Jaap Wildeman, Kimberley Belfor, Lukas Wijaya, V.E.VAn der Noord, et al.

    Photoactivated chemotherapy agents show a promising ability to kill cancer cells under the action of light, including those in chronic hypoxic conditions. Those compounds form a new branch of physically targeted anticancer agents with potentially lower systemic side effects for patients. On the other hand, very few information exists on the intracellular interactions between the photoreleased ruthenium cage and the photoreleased antitcancer inhibitor. In this work, we report a biological study of the photoactivated chemotherapy compound Ru-STF31 in the glioblastoma cancer cell line U87MG. Ru-STF31 targets nicotinamide phosphoribosyltransferase (NAMPT), an enzyme overexpressed in glioblastoma. Ru-STF31 is activated by red-light irradiation, which breaks a bond between the ruthenium-based caging group and the NAMPT inhibitor STF31, thereby releasing two photoproducts: the ruthenium cage and the cytotoxic inhibitor STF31. Ru-STF31 showed significantly higher solubility in water and anticancer efficacy compared with the free inhibitor STF-31. It also significantly decreased intracellular NAD+ levels not only in normoxic (21% O2) but also in hypoxic (1% O2) U87MG cells. Strikingly, NAD+ depletion by red light activation of Ru-STF31 in hypoxic U87MG cells could not be rescued by the addition of extracellular NAD+. Our data suggest an active role of the ruthenium photocage released by light activation.

  • Open Access

    Simple and Efficient Method for Mono‐ and Di‐Amination of Polypyridine N‐Oxides

    by Wessel Verbeet, Yurii Husiev, Sylvestre Bonnet

    Herein we report a simple synthetic route towards both known and novel aminated polypyridyl ligands. The use of tosyl chloride in combination with potassium phthalimide followed by hydrolysis allows for chemo–selective ortho–amination of (poly)pyridyl mono‐ and di‐N‐oxides with good to excellent yield. The reactions are scalable and reproducible while using inexpensive, commercially available reagents.


  • Open Access

    Fungal Anthraquinone Photoantimicrobials Challenge the Dogma of Cationic Photosensitizers

    by Fabian Hammerle, Johannes Fiala, Anja Höck, Lesley Huymann, Pamela Vrabl, Yurii Husiev, Sylvestre Bonnet, Ursula Peintner, Bianka Siewert

    The photoantimicrobial potential of four mushroom species (i.e., Cortinarius cinnabarinus, C. holoxanthus, C. malicorius, and C. sanguineus) was explored by studying the minimal inhibitory concentrations (MIC) via a light-modified broth microdilution assay based on the recommended protocols of the European Committee on Antimicrobial Susceptibility Testing (EUCAST). The extracts were tested against Candida albicans, Escherichia coli, and Staphylococcus aureus under blue (λ = 428 and 478 nm, H = 30 J/cm2) and green light (λ = 528 nm, H = 30 J/cm2) irradiation. Three extracts showed significant photoantimicrobial effects at concentrations below 25 μg/mL. Targeted isolation of the major pigments from C. sanguineus led to the identification of two new potent photoantimicrobials, one of them (i.e., dermocybin) being active against S. aureus and C. albicans under green light irradiation [PhotoMIC530 = 39.5 μM (12.5 μg/mL) and 2.4 μM (0.75 μg/mL), respectively] and the other one (i.e., emodin) being in addition active against E. coli in a low micromolar range [PhotoMIC428 = 11.1 μM (3 μg/mL)]. Intriguingly, dermocybin was not (photo)cytotoxic against the three tested cell lines, adding an additional level of selectivity. Since both photoantimicrobials are not charged, this discovery shifts the paradigm of cationic photosensitizers.